Evaluating the inpatient burden of antimicrobial resistance in hidradenitis suppurativa hospitalizations: a cross-sectional analysis

Arch Dermatol Res. 2024 Apr 25;316(5):131. doi: 10.1007/s00403-024-02860-1.

Authors

Shrey Patel¹, Jamie Katy Hu², Ariel Finberg³, Daphne G Eckembrecher², Francelia J Eckembrecher², Keyvan Nouri²

Affiliations

¹ Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL, 33136, USA. shreypatel.research@gmail.com.
² Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL, 33136, USA.
³ Department of Dermatology, University of Washington School of Medicine, Seattle, WA, USA.

PMID: 38662202
DOI: 10.1007/s00403-024-02860-1

No abstract available

Keywords: Antibiotic; Antimicrobial; Follicle; Hidradenitis suppurativa; Inpatient; NIS; Resistance.

Publication types

Letter

MeSH terms

Adult
Anti-Bacterial Agents / therapeutic use
Cross-Sectional Studies
Drug Resistance, Bacterial
Female
Hidradenitis Suppurativa* / drug therapy
Hospitalization* / statistics & numerical data
Humans
Inpatients / statistics & numerical data
Male
Middle Aged

Substances

Anti-Bacterial Agents